Global Hospital Injectable Drugs Market Growth (Status and Outlook) 2021-2026

  • receipt Report ID : 154554
  • calendar_today Published On: Feb, 2021
  • file_copy Pages: 156
  • list Pharmaceuticals and Healthcare
Buy @ $3660

According to this latest study, the 2020 growth of Hospital Injectable Drugs will have significant change from previous year. By the most conservative estimates of global Hospital Injectable Drugs market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ 37190 million in 2019. Over the next five years the Hospital Injectable Drugs market will register a 4.9% CAGR in terms of revenue, the global market size will reach US$ 45090 million by 2025.

This report presents a comprehensive overview, market shares, and growth opportunities of Hospital Injectable Drugs market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021 in Section 2.3; and forecast to 2026 in section 10.7.

Generic Sterile Injectables

Sterile Intravenous (IV) Solutions

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 10.8.

Oncology

Anesthesia

Anti-Infectives

Parenteral Nutrition

Cardiovascular Diseases

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.

Hospira (Pfizer Inc.)

Baxter

Fresenius Kabi

Sandoz (Novartis)

Hikma Pharmaceuticals PLC

Dr. Reddy’s Laboratories Ltd

Grifols

Nichi-Iko Group (Sagent)

Teva Pharmaceutical

Otsuka

B.Braun

JW Life Science

Auromedics

Sanofi

Gland Pharma

Endo International PLC

Sichuan Kelun Pharmaceutical

Cisen Pharmaceutical

Shijiazhuang No. 4 Pharmaceutical

Shandong Hualu Pharmaceutical

CR Double-Crane

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Hospital Injectable Drugs Market Size 2016-2026

2.1.2 Hospital Injectable Drugs Market Size CAGR by Region 2020 VS 2021 VS 2026

2.2 Hospital Injectable Drugs Segment by Type

2.2.1 Generic Sterile Injectables

2.2.2 Generic Sterile Injectables

2.3 Hospital Injectable Drugs Market Size by Type

2.3.1 Global Hospital Injectable Drugs Market Size CAGR by Type

2.3.2 Global Hospital Injectable Drugs Market Size Market Share by Type (2016-2021)

2.4 Hospital Injectable Drugs Segment by Application

2.4.1 Oncology

2.4.2 Anesthesia

2.4.3 Anti-Infectives

2.4.4 Parenteral Nutrition

2.4.5 Cardiovascular Diseases

2.5 Hospital Injectable Drugs Market Size by Application

2.5.1 Global Hospital Injectable Drugs Market Size CAGR by Application

2.5.2 Global Hospital Injectable Drugs Market Size Market Share by Application (2016-2021)

3 Global Hospital Injectable Drugs by Players

3.1 Hospital Injectable Drugs Market Size Market Share by Players

3.1.1 Global Hospital Injectable Drugs Revenue by Players (2019-2021E)

3.1.2 Global Hospital Injectable Drugs Revenue Market Share by Players (2019-2021E)

3.2 Global Hospital Injectable Drugs Key Players Head office and Products Offered

3.3 Market Concentration Rate Analysis

3.3.1 Competition Landscape Analysis

3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2019-2021E)

3.4 New Products and Potential Entrants

3.5 Mergers & Acquisitions, Expansion

4 Hospital Injectable Drugs by Regions

4.1 Hospital Injectable Drugs Market Size by Regions (2016-2021)

4.2 Americas Hospital Injectable Drugs Market Size Growth (2016-2021)

4.3 APAC Hospital Injectable Drugs Market Size Growth (2016-2021)

4.4 Europe Hospital Injectable Drugs Market Size Growth (2016-2021)

4.5 Middle East & Africa Hospital Injectable Drugs Market Size Growth (2016-2021)

5 Americas

5.1 Americas Hospital Injectable Drugs Market Size by Country (2016-2021)

5.2 Americas Hospital Injectable Drugs Market Size by Type (2016-2021)

5.3 Americas Hospital Injectable Drugs Market Size by Application (2016-2021)

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Hospital Injectable Drugs Market Size by Region (2016-2021)

6.2 APAC Hospital Injectable Drugs Market Size by Type (2016-2021)

6.3 APAC Hospital Injectable Drugs Market Size by Application (2016-2021)

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Hospital Injectable Drugs by Country (2016-2021)

7.2 Europe Hospital Injectable Drugs Market Size by Type (2016-2021)

7.3 Europe Hospital Injectable Drugs Market Size by Application (2016-2021)

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Hospital Injectable Drugs by Region (2016-2021)

8.2 Middle East & Africa Hospital Injectable Drugs Market Size by Type (2016-2021)

8.3 Middle East & Africa Hospital Injectable Drugs Market Size by Application (2016-2021)

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers and Impact

9.1.1 Growing Demand from Key Regions

9.1.2 Growing Demand from Key Applications and Potential Industries

9.2 Market Challenges and Impact

9.3 Market Trends

10 Global Hospital Injectable Drugs Market Forecast

10.1 Global Hospital Injectable Drugs Forecast by Regions (2021-2026)

10.1.1 Global Hospital Injectable Drugs Forecast by Regions (2021-2026)

10.1.2 Americas Hospital Injectable Drugs Forecast

10.1.3 APAC Hospital Injectable Drugs Forecast

10.1.4 Europe Hospital Injectable Drugs Forecast

10.1.5 Middle East & Africa Hospital Injectable Drugs Forecast

10.2 Americas Hospital Injectable Drugs Forecast by Countries (2021-2026)

10.2.1 United States Hospital Injectable Drugs Market Forecast

10.2.2 Canada Hospital Injectable Drugs Market Forecast

10.2.3 Mexico Hospital Injectable Drugs Market Forecast

10.2.4 Brazil Hospital Injectable Drugs Market Forecast

10.3 APAC Hospital Injectable Drugs Forecast by Region (2021-2026)

10.3.1 China Hospital Injectable Drugs Market Forecast

10.3.2 Japan Hospital Injectable Drugs Market Forecast

10.3.3 Korea Hospital Injectable Drugs Market Forecast

10.3.4 Southeast Asia Hospital Injectable Drugs Market Forecast

10.3.5 India Hospital Injectable Drugs Market Forecast

10.3.6 Australia Hospital Injectable Drugs Market Forecast

10.4 Europe Hospital Injectable Drugs Forecast by Country (2021-2026)

10.4.1 Germany Hospital Injectable Drugs Market Forecast

10.4.2 France Hospital Injectable Drugs Market Forecast

10.4.3 UK Hospital Injectable Drugs Market Forecast

10.4.4 Italy Hospital Injectable Drugs Market Forecast

10.4.5 Russia Hospital Injectable Drugs Market Forecast

10.5 Middle East & Africa Hospital Injectable Drugs Forecast by Region (2021-2026)

10.5.1 Egypt Hospital Injectable Drugs Market Forecast

10.5.2 South Africa Hospital Injectable Drugs Market Forecast

10.5.3 Israel Hospital Injectable Drugs Market Forecast

10.5.4 Turkey Hospital Injectable Drugs Market Forecast

10.5.5 GCC Countries Hospital Injectable Drugs Market Forecast

10.6 Global Hospital Injectable Drugs Forecast by Type (2021-2026)

10.8 Global Hospital Injectable Drugs Forecast by Application (2021-2026)

11 Key Players Analysis

11.1 Hospira (Pfizer Inc.)

11.1.1 Hospira (Pfizer Inc.) Company Information

11.1.2 Hospira (Pfizer Inc.) Hospital Injectable Drugs Product Offered

11.1.3 Hospira (Pfizer Inc.) Hospital Injectable Drugs Revenue, Gross Margin and Market Share (2019-2021)

11.1.4 Hospira (Pfizer Inc.) Main Business Overview

11.1.5 Hospira (Pfizer Inc.) Latest Developments

11.2 Baxter

11.2.1 Baxter Company Information

11.2.2 Baxter Hospital Injectable Drugs Product Offered

11.2.3 Baxter Hospital Injectable Drugs Revenue, Gross Margin and Market Share (2019-2021)

11.2.4 Baxter Main Business Overview

11.2.5 Baxter Latest Developments

11.3 Fresenius Kabi

11.3.1 Fresenius Kabi Company Information

11.3.2 Fresenius Kabi Hospital Injectable Drugs Product Offered

11.3.3 Fresenius Kabi Hospital Injectable Drugs Revenue, Gross Margin and Market Share (2019-2021)

11.3.4 Fresenius Kabi Main Business Overview

11.3.5 Fresenius Kabi Latest Developments

11.4 Sandoz (Novartis)

11.4.1 Sandoz (Novartis) Company Information

11.4.2 Sandoz (Novartis) Hospital Injectable Drugs Product Offered

11.4.3 Sandoz (Novartis) Hospital Injectable Drugs Revenue, Gross Margin and Market Share (2019-2021)

11.4.4 Sandoz (Novartis) Main Business Overview

11.4.5 Sandoz (Novartis) Latest Developments

11.5 Hikma Pharmaceuticals PLC

11.5.1 Hikma Pharmaceuticals PLC Company Information

11.5.2 Hikma Pharmaceuticals PLC Hospital Injectable Drugs Product Offered

11.5.3 Hikma Pharmaceuticals PLC Hospital Injectable Drugs Revenue, Gross Margin and Market Share (2019-2021)

11.5.4 Hikma Pharmaceuticals PLC Main Business Overview

11.5.5 Hikma Pharmaceuticals PLC Latest Developments

11.6 Dr. Reddy’s Laboratories Ltd

11.6.1 Dr. Reddy’s Laboratories Ltd Company Information

11.6.2 Dr. Reddy’s Laboratories Ltd Hospital Injectable Drugs Product Offered

11.6.3 Dr. Reddy’s Laboratories Ltd Hospital Injectable Drugs Revenue, Gross Margin and Market Share (2019-2021)

11.6.4 Dr. Reddy’s Laboratories Ltd Main Business Overview

11.6.5 Dr. Reddy’s Laboratories Ltd Latest Developments

11.7 Grifols

11.7.1 Grifols Company Information

11.7.2 Grifols Hospital Injectable Drugs Product Offered

11.7.3 Grifols Hospital Injectable Drugs Revenue, Gross Margin and Market Share (2019-2021)

11.7.4 Grifols Main Business Overview

11.7.5 Grifols Latest Developments

11.8 Nichi-Iko Group (Sagent)

11.8.1 Nichi-Iko Group (Sagent) Company Information

11.8.2 Nichi-Iko Group (Sagent) Hospital Injectable Drugs Product Offered

11.8.3 Nichi-Iko Group (Sagent) Hospital Injectable Drugs Revenue, Gross Margin and Market Share (2019-2021)

11.8.4 Nichi-Iko Group (Sagent) Main Business Overview

11.8.5 Nichi-Iko Group (Sagent) Latest Developments

11.9 Teva Pharmaceutical

11.9.1 Teva Pharmaceutical Company Information

11.9.2 Teva Pharmaceutical Hospital Injectable Drugs Product Offered

11.9.3 Teva Pharmaceutical Hospital Injectable Drugs Revenue, Gross Margin and Market Share (2019-2021)

11.9.4 Teva Pharmaceutical Main Business Overview

11.9.5 Teva Pharmaceutical Latest Developments

11.10 Otsuka

11.10.1 Otsuka Company Information

11.10.2 Otsuka Hospital Injectable Drugs Product Offered

11.10.3 Otsuka Hospital Injectable Drugs Revenue, Gross Margin and Market Share (2019-2021)

11.10.4 Otsuka Main Business Overview

11.10.5 Otsuka Latest Developments

11. B.Braun

11.11.1 B.Braun Company Information

11.11.2 B.Braun Hospital Injectable Drugs Product Offered

11.11.3 B.Braun Hospital Injectable Drugs Revenue, Gross Margin and Market Share (2019-2021)

11.11.4 B.Braun Main Business Overview

11.11.5 B.Braun Latest Developments

11.12 JW Life Science

11.12.1 JW Life Science Company Information

11.12.2 JW Life Science Hospital Injectable Drugs Product Offered

11.12.3 JW Life Science Hospital Injectable Drugs Revenue, Gross Margin and Market Share (2019-2021)

11.12.4 JW Life Science Main Business Overview

11.12.5 JW Life Science Latest Developments

11.13 Auromedics

11.13.1 Auromedics Company Information

11.13.2 Auromedics Hospital Injectable Drugs Product Offered

11.13.3 Auromedics Hospital Injectable Drugs Revenue, Gross Margin and Market Share (2019-2021)

11.13.4 Auromedics Main Business Overview

11.13.5 Auromedics Latest Developments

11.14 Sanofi

11.14.1 Sanofi Company Information

11.14.2 Sanofi Hospital Injectable Drugs Product Offered

11.14.3 Sanofi Hospital Injectable Drugs Revenue, Gross Margin and Market Share (2019-2021)

11.14.4 Sanofi Main Business Overview

11.14.5 Sanofi Latest Developments

11.15 Gland Pharma

11.15.1 Gland Pharma Company Information

11.15.2 Gland Pharma Hospital Injectable Drugs Product Offered

11.15.3 Gland Pharma Hospital Injectable Drugs Revenue, Gross Margin and Market Share (2019-2021)

11.15.4 Gland Pharma Main Business Overview

11.15.5 Gland Pharma Latest Developments

11.16 Endo International PLC

11.16.1 Endo International PLC Company Information

11.16.2 Endo International PLC Hospital Injectable Drugs Product Offered

11.16.3 Endo International PLC Hospital Injectable Drugs Revenue, Gross Margin and Market Share (2019-2021)

11.16.4 Endo International PLC Main Business Overview

11.16.5 Endo International PLC Latest Developments

11.17 Sichuan Kelun Pharmaceutical

11.17.1 Sichuan Kelun Pharmaceutical Company Information

11.17.2 Sichuan Kelun Pharmaceutical Hospital Injectable Drugs Product Offered

11.17.3 Sichuan Kelun Pharmaceutical Hospital Injectable Drugs Revenue, Gross Margin and Market Share (2019-2021)

11.17.4 Sichuan Kelun Pharmaceutical Main Business Overview

11.17.5 Sichuan Kelun Pharmaceutical Latest Developments

11.18 Cisen Pharmaceutical

11.18.1 Cisen Pharmaceutical Company Information

11.18.2 Cisen Pharmaceutical Hospital Injectable Drugs Product Offered

11.18.3 Cisen Pharmaceutical Hospital Injectable Drugs Revenue, Gross Margin and Market Share (2019-2021)

11.18.4 Cisen Pharmaceutical Main Business Overview

11.18.5 Cisen Pharmaceutical Latest Developments

11.19 Shijiazhuang No. 4 Pharmaceutical

11.19.1 Shijiazhuang No. 4 Pharmaceutical Company Information

11.19.2 Shijiazhuang No. 4 Pharmaceutical Hospital Injectable Drugs Product Offered

11.19.3 Shijiazhuang No. 4 Pharmaceutical Hospital Injectable Drugs Revenue, Gross Margin and Market Share (2019-2021)

11.19.4 Shijiazhuang No. 4 Pharmaceutical Main Business Overview

11.19.5 Shijiazhuang No. 4 Pharmaceutical Latest Developments

11.20 Shandong Hualu Pharmaceutical

11.20.1 Shandong Hualu Pharmaceutical Company Information

11.20.2 Shandong Hualu Pharmaceutical Hospital Injectable Drugs Product Offered

11.20.3 Shandong Hualu Pharmaceutical Hospital Injectable Drugs Revenue, Gross Margin and Market Share (2019-2021)

11.20.4 Shandong Hualu Pharmaceutical Main Business Overview

11.20.5 Shandong Hualu Pharmaceutical Latest Developments

11.21 CR Double-Crane

11.21.1 CR Double-Crane Company Information

11.21.2 CR Double-Crane Hospital Injectable Drugs Product Offered

11.21.3 CR Double-Crane Hospital Injectable Drugs Revenue, Gross Margin and Market Share (2019-2021)

11.21.4 CR Double-Crane Main Business Overview

11.21.5 CR Double-Crane Latest Developments

12 Research Findings and Conclusion

List of Tables

Table 1. Hospital Injectable Drugs Market Size CAGR by Region (2020-2026) & ($ Millions)

Table 2. Major Players of Generic Sterile Injectables

Table 3. Major Players of Sterile Intravenous (IV) Solutions

Table 4. Hospital Injectable Drugs Market Size CAGR by Type (2016-2021) & ($ Millions)

Table 5. Global Hospital Injectable Drugs Market Size by Type (2016-2021) & ($ Millions)

Table 6. Global Hospital Injectable Drugs Market Size Market Share by Type (2016-2021)

Table 7. Hospital Injectable Drugs Market Size CAGR by Application (2016-2021) & ($ Millions)

Table 8. Global Hospital Injectable Drugs Market Size by Application (2016-2021) & ($ Millions)

Table 9. Global Hospital Injectable Drugs Market Size Market Share by Application (2016-2021)

Table 10. Global Hospital Injectable Drugs Revenue by Players (2019-2021E) & ($ Millions)

Table 11. Global Hospital Injectable Drugs Revenue Market Share by Players (2019-2021E)

Table 12. Global Hospital Injectable Drugs Key Players Head office and Products Offered

Table 13. Hospital Injectable Drugs Concentration Ratio (CR3, CR5 and CR10) & (2019-2021E)

Table 14. New Products and Potential Entrants

Table 15. Mergers & Acquisitions, Expansion

Table 16. Global Hospital Injectable Drugs Market Size by Regions 2016-2021 & ($ Millions)

Table 17. Global Hospital Injectable Drugs Market Size Market Share by Regions 2016-2021

Table 18. Americas Hospital Injectable Drugs Market Size by Country (2016-2021) & ($ Millions)

Table 19. Americas Hospital Injectable Drugs Market Size Market Share by Country (2016-2021)

Table 20. Americas Hospital Injectable Drugs Market Size by Type (2016-2021) & ($ Millions)

Table 21. Americas Hospital Injectable Drugs Market Size Market Share by Type (2016-2021)

Table 22. Americas Hospital Injectable Drugs Market Size by Application (2016-2021) & ($ Millions)

Table 23. Americas Hospital Injectable Drugs Market Size Market Share by Application (2016-2021)

Table 24. APAC Hospital Injectable Drugs Market Size by Region (2016-2021) & ($ Millions)

Table 25. APAC Hospital Injectable Drugs Market Size Market Share by Region (2016-2021)

Table 26. APAC Hospital Injectable Drugs Market Size by Type (2016-2021) & ($ Millions)

Table 27. APAC Hospital Injectable Drugs Market Size Market Share by Type (2016-2021)

Table 28. APAC Hospital Injectable Drugs Market Size by Application (2016-2021) & ($ Millions)

Table 29. APAC Hospital Injectable Drugs Market Size Market Share by Application (2016-2021)

Table 30. Europe Hospital Injectable Drugs Market Size by Country (2016-2021) & ($ Millions)

Table 31. Europe Hospital Injectable Drugs Market Size Market Share by Country (2016-2021)

Table 32. Europe Hospital Injectable Drugs Market Size by Type (2016-2021) & ($ Millions)

Table 33. Europe Hospital Injectable Drugs Market Size Market Share by Type (2016-2021)

Table 34. Europe Hospital Injectable Drugs Market Size by Application (2016-2021) & ($ Millions)

Table 35. Europe Hospital Injectable Drugs Market Size Market Share by Application (2016-2021)

Table 36. Middle East & Africa Hospital Injectable Drugs Market Size by Region (2016-2021) & ($ Millions)

Table 37. Middle East & Africa Hospital Injectable Drugs Market Size Market Share by Region (2016-2021)

Table 38. Middle East & Africa Hospital Injectable Drugs Market Size by Type (2016-2021) & ($ Millions)

Table 39. Middle East & Africa Hospital Injectable Drugs Market Size Market Share by Type (2016-2021)

Table 40. Middle East & Africa Hospital Injectable Drugs Market Size by Application (2016-2021) & ($ Millions)

Table 41. Middle East & Africa Hospital Injectable Drugs Market Size Market Share by Application (2016-2021)

Table 42. Key and Potential Regions of Hospital Injectable Drugs

Table 43. Key Application and Potential Industries of Hospital Injectable Drugs

Table 44. Key Challenges of Hospital Injectable Drugs

Table 45. Key Trends of Hospital Injectable Drugs

Table 46. Global Hospital Injectable Drugs Market Size Forecast by Regions (2021-2026) & ($ Millions)

Table 47. Global Hospital Injectable Drugs Market Size Market Share Forecast by Regions

Table 48. Global Hospital Injectable Drugs Market Size Forecast by Type (2021-2026) & ($ Millions)

Table 49. Global Hospital Injectable Drugs Market Size Market Share Forecast by Type (2021-2026)

Table 50. Global Hospital Injectable Drugs Market Size Forecast by Application (2021-2026) & ($ Millions)

Table 51. Global Hospital Injectable Drugs Market Size Market Share Forecast by Application (2021-2026)

Table 52. Hospira (Pfizer Inc.) Details, Company Type, Hospital Injectable Drugs Area Served and Its Competitors

Table 53. Hospira (Pfizer Inc.) Hospital Injectable Drugs Product Offered

Table 54. Hospira (Pfizer Inc.) Hospital Injectable Drugs Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 55. Hospira (Pfizer Inc.) Main Business

Table 56. Hospira (Pfizer Inc.) Latest Developments

Table 57. Baxter Details, Company Type, Hospital Injectable Drugs Area Served and Its Competitors

Table 58. Baxter Hospital Injectable Drugs Product Offered

Table 59. Baxter Main Business

Table 60. Baxter Hospital Injectable Drugs Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 61. Baxter Latest Developments

Table 62. Fresenius Kabi Details, Company Type, Hospital Injectable Drugs Area Served and Its Competitors

Table 63. Fresenius Kabi Hospital Injectable Drugs Product Offered

Table 64. Fresenius Kabi Main Business

Table 65. Fresenius Kabi Hospital Injectable Drugs Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 66. Fresenius Kabi Latest Developments

Table 67. Sandoz (Novartis) Details, Company Type, Hospital Injectable Drugs Area Served and Its Competitors

Table 68. Sandoz (Novartis) Hospital Injectable Drugs Product Offered

Table 69. Sandoz (Novartis) Main Business

Table 70. Sandoz (Novartis) Hospital Injectable Drugs Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 71. Sandoz (Novartis) Latest Developments

Table 72. Hikma Pharmaceuticals PLC Details, Company Type, Hospital Injectable Drugs Area Served and Its Competitors

Table 73. Hikma Pharmaceuticals PLC Hospital Injectable Drugs Product Offered

Table 74. Hikma Pharmaceuticals PLC Main Business

Table 75. Hikma Pharmaceuticals PLC Hospital Injectable Drugs Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 76. Hikma Pharmaceuticals PLC Latest Developments

Table 77. Dr. Reddy’s Laboratories Ltd Details, Company Type, Hospital Injectable Drugs Area Served and Its Competitors

Table 78. Dr. Reddy’s Laboratories Ltd Hospital Injectable Drugs Product Offered

Table 79. Dr. Reddy’s Laboratories Ltd Main Business

Table 80. Dr. Reddy’s Laboratories Ltd Hospital Injectable Drugs Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 81. Dr. Reddy’s Laboratories Ltd Latest Developments

Table 82. Grifols Details, Company Type, Hospital Injectable Drugs Area Served and Its Competitors

Table 83. Grifols Hospital Injectable Drugs Product Offered

Table 84. Grifols Main Business

Table 85. Grifols Hospital Injectable Drugs Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 86. Grifols Latest Developments

Table 87. Nichi-Iko Group (Sagent) Details, Company Type, Hospital Injectable Drugs Area Served and Its Competitors

Table 88. Nichi-Iko Group (Sagent) Hospital Injectable Drugs Product Offered

Table 89. Nichi-Iko Group (Sagent) Main Business

Table 90. Nichi-Iko Group (Sagent) Hospital Injectable Drugs Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 91. Nichi-Iko Group (Sagent) Latest Developments

Table 92. Teva Pharmaceutical Details, Company Type, Hospital Injectable Drugs Area Served and Its Competitors

Table 93. Teva Pharmaceutical Hospital Injectable Drugs Product Offered

Table 94. Teva Pharmaceutical Main Business

Table 95. Teva Pharmaceutical Hospital Injectable Drugs Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 96. Teva Pharmaceutical Latest Developments

Table 97. Otsuka Details, Company Type, Hospital Injectable Drugs Area Served and Its Competitors

Table 98. Otsuka Hospital Injectable Drugs Product Offered

Table 99. Otsuka Main Business

Table 100. Otsuka Hospital Injectable Drugs Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 101. Otsuka Latest Developments

Table 102. B.Braun Details, Company Type, Hospital Injectable Drugs Area Served and Its Competitors

Table 103. B.Braun Hospital Injectable Drugs Product Offered

Table 104. B.Braun Hospital Injectable Drugs Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 105. B.Braun Main Business

Table 106. B.Braun Latest Developments

Table 107. JW Life Science Details, Company Type, Hospital Injectable Drugs Area Served and Its Competitors

Table 108. JW Life Science Hospital Injectable Drugs Product Offered

Table 109. JW Life Science Main Business

Table 110. JW Life Science Hospital Injectable Drugs Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 111. JW Life Science Latest Developments

Table 112. Auromedics Details, Company Type, Hospital Injectable Drugs Area Served and Its Competitors

Table 113. Auromedics Hospital Injectable Drugs Product Offered

Table 114. Auromedics Main Business

Table 115. Auromedics Hospital Injectable Drugs Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 116. Auromedics Latest Developments

Table 117. Sanofi Details, Company Type, Hospital Injectable Drugs Area Served and Its Competitors

Table 118. Sanofi Hospital Injectable Drugs Product Offered

Table 119. Sanofi Main Business

Table 120. Sanofi Hospital Injectable Drugs Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 121. Sanofi Latest Developments

Table 122. Gland Pharma Details, Company Type, Hospital Injectable Drugs Area Served and Its Competitors

Table 123. Gland Pharma Hospital Injectable Drugs Product Offered

Table 124. Gland Pharma Main Business

Table 125. Gland Pharma Hospital Injectable Drugs Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 126. Gland Pharma Latest Developments

Table 127. Endo International PLC Details, Company Type, Hospital Injectable Drugs Area Served and Its Competitors

Table 128. Endo International PLC Hospital Injectable Drugs Product Offered

Table 129. Endo International PLC Main Business

Table 130. Endo International PLC Hospital Injectable Drugs Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 131. Endo International PLC Latest Developments

Table 132. Sichuan Kelun Pharmaceutical Details, Company Type, Hospital Injectable Drugs Area Served and Its Competitors

Table 133. Sichuan Kelun Pharmaceutical Hospital Injectable Drugs Product Offered

Table 134. Sichuan Kelun Pharmaceutical Main Business

Table 135. Sichuan Kelun Pharmaceutical Hospital Injectable Drugs Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 136. Sichuan Kelun Pharmaceutical Latest Developments

Table 137. Cisen Pharmaceutical Details, Company Type, Hospital Injectable Drugs Area Served and Its Competitors

Table 138. Cisen Pharmaceutical Hospital Injectable Drugs Product Offered

Table 139. Cisen Pharmaceutical Main Business

Table 140. Cisen Pharmaceutical Hospital Injectable Drugs Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 141. Cisen Pharmaceutical Latest Developments

Table 142. Shijiazhuang No. 4 Pharmaceutical Details, Company Type, Hospital Injectable Drugs Area Served and Its Competitors

Table 143. Shijiazhuang No. 4 Pharmaceutical Hospital Injectable Drugs Product Offered

Table 144. Shijiazhuang No. 4 Pharmaceutical Main Business

Table 145. Shijiazhuang No. 4 Pharmaceutical Hospital Injectable Drugs Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 146. Shijiazhuang No. 4 Pharmaceutical Latest Developments

Table 147. Shandong Hualu Pharmaceutical Details, Company Type, Hospital Injectable Drugs Area Served and Its Competitors

Table 148. Shandong Hualu Pharmaceutical Hospital Injectable Drugs Product Offered

Table 149. Shandong Hualu Pharmaceutical Main Business

Table 150. Shandong Hualu Pharmaceutical Hospital Injectable Drugs Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 151. Shandong Hualu Pharmaceutical Latest Developments

Table 152. CR Double-Crane Details, Company Type, Hospital Injectable Drugs Area Served and Its Competitors

Table 153. CR Double-Crane Hospital Injectable Drugs Product Offered

Table 154. CR Double-Crane Hospital Injectable Drugs Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 155. CR Double-Crane Main Business

Table 156. CR Double-Crane Latest Developments

List of Figures

Figure 1. Hospital Injectable Drugs Report Years Considered

Figure 2. Research Objectives

Figure 3. Research Methodology

Figure 4. Research Process and Data Source

Figure 5. Global Hospital Injectable Drugs Market Size Growth Rate 2016-2026 ($ Millions)

Figure 6. Global Hospital Injectable Drugs Market Size Market Share by Type (2016-2021)

Figure 7. Hospital Injectable Drugs in Oncology

Figure 8. Global Hospital Injectable Drugs Market: Oncology (2016-2021) & ($ Millions)

Figure 9. Hospital Injectable Drugs in Anesthesia

Figure 10. Global Hospital Injectable Drugs Market: Anesthesia (2016-2021) & ($ Millions)

Figure 11. Hospital Injectable Drugs in Anti-Infectives

Figure 12. Global Hospital Injectable Drugs Market: Anti-Infectives (2016-2021) & ($ Millions)

Figure 13. Hospital Injectable Drugs in Parenteral Nutrition

Figure 14. Global Hospital Injectable Drugs Market: Parenteral Nutrition (2016-2021) & ($ Millions)

Figure 15. Hospital Injectable Drugs in Cardiovascular Diseases

Figure 16. Global Hospital Injectable Drugs Market: Cardiovascular Diseases (2016-2021) & ($ Millions)

Figure 17. Global Hospital Injectable Drugs Market Size Market Share by Application in 2020

Figure 18. Global Hospital Injectable Drugs Revenue Market Share by Player in 2020

Figure 19. Global Hospital Injectable Drugs Market Size Market Share by Regions (2016-2021)

Figure 20. Americas Hospital Injectable Drugs Market Size 2016-2021 ($ Millions)

Figure 21. APAC Hospital Injectable Drugs Market Size 2016-2021 ($ Millions)

Figure 22. Europe Hospital Injectable Drugs Market Size 2016-2021 ($ Millions)

Figure 23. Middle East & Africa Hospital Injectable Drugs Market Size 2016-2021 ($ Millions)

Figure 24. Americas Hospital Injectable Drugs Market Size Market Share by Country in 2020

Figure 25. Americas Hospital Injectable Drugs Market Size Market Share by Type in 2020

Figure 26. Americas Hospital Injectable Drugs Market Size Market Share by Application in 2020

Figure 27. United States Hospital Injectable Drugs Market Size Growth 2016-2021 ($ Millions)

Figure 28. Canada Hospital Injectable Drugs Market Size Growth 2016-2021 ($ Millions)

Figure 29. Mexico Hospital Injectable Drugs Market Size Growth 2016-2021 ($ Millions)

Figure 30. APAC Hospital Injectable Drugs Market Size Market Share by Regions in 2020

Figure 31. APAC Hospital Injectable Drugs Market Size Market Share by Type in 2020

Figure 32. APAC Hospital Injectable Drugs Market Size Market Share by Application in 2020

Figure 33. China Hospital Injectable Drugs Market Size Growth 2016-2021 ($ Millions)

Figure 34. Japan Hospital Injectable Drugs Market Size Growth 2016-2021 ($ Millions)

Figure 35. Korea Hospital Injectable Drugs Market Size Growth 2016-2021 ($ Millions)

Figure 36. Southeast Asia Hospital Injectable Drugs Market Size Growth 2016-2021 ($ Millions)

Figure 37. India Hospital Injectable Drugs Market Size Growth 2016-2021 ($ Millions)

Figure 38. Australia Hospital Injectable Drugs Market Size Growth 2016-2021 ($ Millions)

Figure 39. Europe Hospital Injectable Drugs Market Size Market Share by Countries in 2020

Figure 40. Europe Hospital Injectable Drugs Market Size Market Share by Type in 2020

Figure 41. Europe Hospital Injectable Drugs Market Size Market Share by Application in 2020

Figure 42. Germany Hospital Injectable Drugs Market Size Growth 2016-2021 ($ Millions)

Figure 43. France Hospital Injectable Drugs Market Size Growth 2016-2021 ($ Millions)

Figure 44. UK Hospital Injectable Drugs Market Size Growth 2016-2021 ($ Millions)

Figure 45. Italy Hospital Injectable Drugs Market Size Growth 2016-2021 ($ Millions)

Figure 46. Russia Hospital Injectable Drugs Market Size Growth 2016-2021 ($ Millions)

Figure 47. Middle East & Africa Hospital Injectable Drugs Market Size Market Share by Region in 2020

Figure 48. Middle East & Africa Hospital Injectable Drugs Market Size Market Share by Type in 2020

Figure 49. Middle East & Africa Hospital Injectable Drugs Market Size Market Share by Application in 2020

Figure 50. Egypt Hospital Injectable Drugs Market Size Growth 2016-2021 ($ Millions)

Figure 51. South Africa Hospital Injectable Drugs Market Size Growth 2016-2021 ($ Millions)

Figure 52. Israel Hospital Injectable Drugs Market Size Growth 2016-2021 ($ Millions)

Figure 53. Turkey Hospital Injectable Drugs Market Size Growth 2016-2021 ($ Millions)

Figure 54. GCC Countries Hospital Injectable Drugs Market Size Growth 2016-2021 ($ Millions)

Figure 55. Americas Hospital Injectable Drugs Market Size 2021-2026 ($ Millions)

Figure 56. APAC Hospital Injectable Drugs Market Size 2021-2026 ($ Millions)

Figure 57. Europe Hospital Injectable Drugs Market Size 2021-2026 ($ Millions)

Figure 58. Middle East & Africa Hospital Injectable Drugs Market Size 2021-2026 ($ Millions)

Figure 59. United States Hospital Injectable Drugs Market Size 2021-2026 ($ Millions)

Figure 60. Canada Hospital Injectable Drugs Market Size 2021-2026 ($ Millions)

Figure 61. Mexico Hospital Injectable Drugs Market Size 2021-2026 ($ Millions)

Figure 62. Brazil Hospital Injectable Drugs Market Size 2021-2026 ($ Millions)

Figure 63. China Hospital Injectable Drugs Market Size 2021-2026 ($ Millions)

Figure 64. Japan Hospital Injectable Drugs Market Size 2021-2026 ($ Millions)

Figure 65. Korea Hospital Injectable Drugs Market Size 2021-2026 ($ Millions)

Figure 66. Southeast Asia Hospital Injectable Drugs Market Size 2021-2026 ($ Millions)

Figure 67. India Hospital Injectable Drugs Market Size 2021-2026 ($ Millions)

Figure 68. Australia Hospital Injectable Drugs Market Size 2021-2026 ($ Millions)

Figure 69. Germany Hospital Injectable Drugs Market Size 2021-2026 ($ Millions)

Figure 70. France Hospital Injectable Drugs Market Size 2021-2026 ($ Millions)

Figure 71. UK Hospital Injectable Drugs Market Size 2021-2026 ($ Millions)

Figure 72. Italy Hospital Injectable Drugs Market Size 2021-2026 ($ Millions)

Figure 73. Russia Hospital Injectable Drugs Market Size 2021-2026 ($ Millions)

Figure 74. Spain Hospital Injectable Drugs Market Size 2021-2026 ($ Millions)

Figure 75. Egypt Hospital Injectable Drugs Market Size 2021-2026 ($ Millions)

Figure 76. South Africa Hospital Injectable Drugs Market Size 2021-2026 ($ Millions)

Figure 77. Israel Hospital Injectable Drugs Market Size 2021-2026 ($ Millions)

Figure 78. Turkey Hospital Injectable Drugs Market Size 2021-2026 ($ Millions)

Figure 79. GCC Countries Hospital Injectable Drugs Market Size 2021-2026 ($ Millions)